首页>
外国专利>
COMPOSITE ANTI-RESTENOSIS DRUG FOR CORONARY DRUG-ELUTING STENT, AND CONTROLLED RELEASE SYSTEM THEREOF
COMPOSITE ANTI-RESTENOSIS DRUG FOR CORONARY DRUG-ELUTING STENT, AND CONTROLLED RELEASE SYSTEM THEREOF
展开▼
机译:冠状动脉洗脱支架的复合抗肿瘤药及其控制释放系统
展开▼
页面导航
摘要
著录项
相似文献
摘要
A composite anti-restenosis drug for use with a coronary drug-eluting stent, and a controlled release system for the drug. The composite drug comprises arsenic trioxide and rapamycin, which may be used in combination to prevent in-stent restenosis and reduce the incidence of intravascular thrombosis. The controlled release system for the composite drug may control the release of the composite drug so as to achieve the therapeutic effect of controlling restenosis and preventing the formation of thromboses.
展开▼